Dr. Kate O’Brien, executive director of the International Vaccine Access Center in the department of international health at the Johns Hopkins Bloomberg School of Public Health, has been appointed director of World Health Organization Department of Immunization, Vaccines and Biologicals.
Dr. O’Brien served as IVAC’s Executive Director for six years. Dr. O’Brien’s career in vaccines and immunizations over the past 25 years at the Bloomberg School was sparked by her field experience in Haiti caring for children who needlessly suffered from vaccine-preventable diseases. Her contributions to on-the-ground field research in vaccine clinical trials, disease epidemiology and vaccine impact studies have extended to policy- and implementation-oriented work in countries throughout Africa and South Asia. Under her direction, the department and IVAC have helped strengthen global immunization programs, especially over the past 15 years since the beginning of IVAC’s work as PneumoADIP.
Dr. O’Brien has served as a member of the WHO Strategic Advisory Group of Experts (SAGE) on Immunization and is also a member of the Gavi board.
Dr. William Moss, professor in the Bloomberg School’s department of epidemiology and IVAC’s deputy director, has been named IVAC’s interim executive director.